The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer
Non-small-cell lung cancer (NSCLC) is a highly heterogeneous disease that is frequently associated with a host of known oncogenic alterations. Advances in molecular diagnostics and drug development have facilitated the targeting of novel alterations such that the majority of NSCLC patients have driv...
Saved in:
Main Authors: | Barbara Melosky, Rosalyn A. Juergens, Shantanu Banerji, Adrian Sacher, Paul Wheatley-Price, Stephanie Snow, Ming-Sound Tsao, Natasha B. Leighl, Ilidio Martins, Parneet Cheema, Geoffrey Liu, Quincy S. C. Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359241308784 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ancillary Testing in Lung Cancer Diagnosis
by: William Dubinski, et al.
Published: (2012-01-01) -
Molecular Alterations of KIT Oncogene in Gliomas
by: Ana L. Gomes, et al.
Published: (2007-01-01) -
Polyoma BK Virus: An Oncogenic Virus?
by: Syed Hassan, et al.
Published: (2013-01-01) -
The Relevance of Oncogene-Induced Apoptosis in Cancer
by: Gerard Evan
Published: (2001-01-01) -
Next-generation ctDNA-driven clinical trials in precision immuno-oncology
by: Charu Aggarwal, et al.
Published: (2023-01-01)